Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Cash from Financing Activities (2020 - 2021)

Historic Cash from Financing Activities for Design Therapeutics (DSGN) over the last 2 years, with Q4 2021 value amounting to $193000.0.

  • Design Therapeutics' Cash from Financing Activities rose 1920000.0% to $193000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $379.2 million, marking a year-over-year increase of 75154.72%. This contributed to the annual value of $513000.0 for FY2024, which is 2914.36% down from last year.
  • Design Therapeutics' Cash from Financing Activities amounted to $193000.0 in Q4 2021, which was up 1920000.0% from $30000.0 recorded in Q3 2021.
  • Design Therapeutics' Cash from Financing Activities' 5-year high stood at $379.0 million during Q1 2021, with a 5-year trough of $1000.0 in Q4 2020.